KeyBanc upgraded PRA Health Sciences (NASDAQ: PRAH) from Sector Weight to Overweight with a price target of $55. Analyst Donald ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE